MANE

Veradermics, Inc

NYSE · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Veradermics is a clinical-stage pharmaceutical company developing prescription treatments for dermatological conditions, including scalp and skin disorders such as androgenetic alopecia.

Industry

Pharmaceutical Preparations

Headquarters

New Haven, CT

Exchange

NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
MONTANOVA CAPITAL, LLCInsider	Sell	$6.37M	59,399at $107.25	Aug 19, 2026
MONTANOVA CAPITAL, LLCInsider	Sell	$74.07M	690,601at $107.25	Aug 19, 2026
Waldman Reid AlexanderChief Executive Officer	Sell	$2.71M	25,234at $107.53	Aug 17, 2026
Durso Timothy AugustChief Technical Officer	Sell	$1.82M	16,767at $108.38	Aug 17, 2026
Durso Timothy AugustChief Technical Officer	Sell	$1.75M	16,306at $107.52	Aug 17, 2026
Waldman Reid AlexanderChief Executive Officer	Sell	$1.23M	11,527at $106.72	Aug 17, 2026
Waldman Reid AlexanderChief Executive Officer	Sell	$2.98M	27,490at $108.45	Aug 17, 2026
Durso Timothy AugustChief Technical Officer	Sell	$257K	2,348at $109.34	Aug 17, 2026
Durso Timothy AugustChief Technical Officer	Sell	$18K	161at $111.28	Aug 17, 2026
Waldman Reid AlexanderChief Executive Officer	Sell	$28K	249at $111.28	Aug 17, 2026
Durso Timothy AugustChief Technical Officer	Sell	$845K	7,918at $106.71	Aug 17, 2026
Waldman Reid AlexanderChief Executive Officer	Sell	$328K	3,000at $109.38	Aug 17, 2026
CHILDS JOHN WDirector	Sell	$8.58M	80,000at $107.23	Aug 12, 2026
CHILDS JOHN WDirector	Sell	$1.59M	15,000at $106.14	Aug 12, 2026
CHILDS JOHN WDirector	Sell	$541K	5,000at $108.24	Aug 12, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for MANE.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable MANE activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

US mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.